Duo arrested after Mephedrone worth Rs 11.5 lakh seized in Nalasopara

The seized drug weighed 115 grams and is collectively worth Rs 11.50 lakh, police said.

Published On 2022-05-29 05:00 GMT   |   Update On 2022-05-29 05:00 GMT

Palghar: Police have arrested two Nigerian nationals from Nalasopara in Maharashtra's Palghar district for allegedly possessing mephedrone, a banned drug, worth Rs 11.50 lakh, an official said on Saturday.

The Anti Narcotics Cell (ANC) of the Mira Bhayandar-Vasai Virar (MBVV) police arrested the duo on Friday, he said.

An offence was registered against the two accused – Austin Omaka (45) and his accomplice Joseph Emmanual (36) – under the Narcotic Drugs and Psychotropic Substances (NDPS) Act at Tulinj police station, MBVV police spokesperson Balram Palkar said, adding the both of them hail from Lagos city of Nigeria.

"Acting on a tip-off, a police team laid a trap and first nabbed Omaka, from whose possession 60 grams of mephedrone worth Rs 6 lakh was recovered. Later, his associate Emmanual was held and 55 grams of the drug valued at Rs 5.50 lakh, was seized from him," he said.

The seized drug weighed 115 grams and is collectively worth Rs 11.50 lakh, police said.

The police are trying to ascertain the source of the drug and to whom it was meant to be sold.

Read also: Afghan resident apprehended at IGI airport with brain tumour drug worth Rs 64 lakh



Tags:    
Article Source : PTI

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News